[go: up one dir, main page]

PL2094693T3 - Sposób przygotowania solifenacyny - Google Patents

Sposób przygotowania solifenacyny

Info

Publication number
PL2094693T3
PL2094693T3 PL07855994T PL07855994T PL2094693T3 PL 2094693 T3 PL2094693 T3 PL 2094693T3 PL 07855994 T PL07855994 T PL 07855994T PL 07855994 T PL07855994 T PL 07855994T PL 2094693 T3 PL2094693 T3 PL 2094693T3
Authority
PL
Poland
Prior art keywords
solifenacin
pharmaceutically acceptable
base
hydrogen tartrate
transformed
Prior art date
Application number
PL07855994T
Other languages
English (en)
Inventor
Josef Jirman
Richard Junek
Original Assignee
Zentiva Ks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentiva Ks filed Critical Zentiva Ks
Publication of PL2094693T3 publication Critical patent/PL2094693T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
PL07855994T 2006-12-22 2007-12-21 Sposób przygotowania solifenacyny PL2094693T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CZ20060828A CZ300692B6 (cs) 2006-12-22 2006-12-22 Zpusob prípravy solifenacinu
PCT/CZ2007/000119 WO2008077357A2 (en) 2006-12-22 2007-12-21 A method for the preparation of solifenacin
EP07855994A EP2094693B1 (en) 2006-12-22 2007-12-21 A method for the preparation of solifenacin

Publications (1)

Publication Number Publication Date
PL2094693T3 true PL2094693T3 (pl) 2012-04-30

Family

ID=39327062

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07855994T PL2094693T3 (pl) 2006-12-22 2007-12-21 Sposób przygotowania solifenacyny

Country Status (9)

Country Link
US (1) US20100145055A1 (pl)
EP (1) EP2094693B1 (pl)
AT (1) ATE533764T1 (pl)
CZ (1) CZ300692B6 (pl)
EA (1) EA015365B1 (pl)
ES (1) ES2375668T3 (pl)
PL (1) PL2094693T3 (pl)
UA (1) UA96974C2 (pl)
WO (1) WO2008077357A2 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100298371A1 (en) 2007-12-04 2010-11-25 Mayank Ghanshyambhai Dave Process for preparing chemically and chirally pure solifenacin base and its salts
SI3067353T1 (en) 2008-07-29 2018-03-30 Krka, D.D., Novo Mesto Process for the preparation of solifenacin salts and their inclusion in pharmaceutical dosage forms
SI2590973T1 (sl) 2010-07-05 2017-01-31 Crystal Pharma, S.A.U. Soli solifenacina
CN102887894A (zh) * 2011-07-18 2013-01-23 天津市医药集团技术发展有限公司 一种琥珀酸索利那新晶型及其制备方法
KR101427221B1 (ko) * 2012-08-29 2014-08-13 주식회사 에스텍파마 플루복사민 자유 염기의 정제방법 및 이를 이용한 고순도 플루복사민 말레이트의 제조방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52108992A (en) * 1976-03-10 1977-09-12 Meiji Seika Kaisha Ltd Purification of cefalexin
NO2005012I1 (no) * 1994-12-28 2005-06-06 Debio Rech Pharma Sa Triptorelin og farmasoytisk akseptable salter derav
CA2558877A1 (en) * 2004-02-09 2005-08-18 Astellas Pharma Inc. Solifenacin succinate-containing composition
CA2560080A1 (en) * 2004-03-16 2005-09-22 Astellas Pharma Inc. Solifenacin-containing composition
JP3701964B1 (ja) * 2005-03-08 2005-10-05 アステラス製薬株式会社 キヌクリジン誘導体の新規な塩

Also Published As

Publication number Publication date
EP2094693A2 (en) 2009-09-02
CZ300692B6 (cs) 2009-07-15
EA015365B1 (ru) 2011-06-30
US20100145055A1 (en) 2010-06-10
EP2094693B1 (en) 2011-11-16
ES2375668T3 (es) 2012-03-05
EA200900744A1 (ru) 2009-12-30
ATE533764T1 (de) 2011-12-15
WO2008077357A2 (en) 2008-07-03
UA96974C2 (ru) 2011-12-26
WO2008077357A3 (en) 2008-08-14
CZ2006828A3 (cs) 2008-07-02

Similar Documents

Publication Publication Date Title
PL2094693T3 (pl) Sposób przygotowania solifenacyny
AU2012248061C1 (en) Inhibitor of sodium-dependent glucose transport protein and preparation method therefor and use thereof
MX2011011245A (es) Proceso para la preparacion de compuestos de morfinano.
EP2412700A4 (en) PROCESS FOR PREPARING A BICYCLIC GAMMA AMINO ACID DERIVATIVE
WO2008109156A3 (en) Process for the preparation of quaternary n-alkyl morphinan alkaloid salts
NZ599342A (en) Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors
PH12015501226A1 (en) Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing the same
IL222085A (en) Process for preparation of lapatinib or salts acceptable for pharmaceutical purposes, process for crystallization of crystalline monoydrate ditosylate lapatinib, process for preparation of compound according to formula (ix), compound according to formula (ix) and xa, and crystal according to formula (ix)
WO2010026603A3 (en) Novel amine salts of tenofovir, process for producing the same and use thereof in production of tenofovir dioproxil
TW200643020A (en) Crystalline form of a quinolinone-carboxamide compound
WO2008087557A3 (en) An improved process for preparation of 9-hydroxy-3-(2-chloroethyl)- 2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one hydrochloride
WO2011050095A3 (en) Prevention and treatment of post-operative cognitive dysfunction (pocd)
MX2009009141A (es) Formas cristalinas de un compuesto de 8-azabiciclo[3,2,1]octano.
IL187640A0 (en) Method for preparing clopidogrel and intermediates used therein
WO2009076602A8 (en) 5-alkyl/alkenyl-3-cyanopyridines as kinase inhibitors
UA94614C2 (en) Process for the preparation of solifenacin
WO2007096875A3 (en) Novel polymorphs of montelukast ammonium salts and processes for preparation therefor
WO2009125425A3 (en) Improved process for the preparation of (s.s)-2.8-diazabicyclo[4.3.0]nonane
ZA201003718B (en) Stable crystalline salt of (r)-3-flurirphenyl-3,4,5-trifluorobenzylcaramic acid 1-azabicyclo [2.2.2] oct-3-yl ester
AU2010277620A8 (en) Ring-annulated dihydropyrrolo[2,l-a]isoquinolines
WO2013117869A3 (fr) Procédé de synthèse enzymatique de l'acide (7s)-3,4-dimethoxybicyclo [4.2.0]|octa-1,3,5-triene-7-carboxylique ou de ses esters, et application a la synthèse|de l'ivabradine et de ses sels
WO2006013550A3 (en) Process for preparation of piperidine carboxylic acid
MX2010002300A (es) Polimorfos de sal sodica del acido (3-(((4-terc-butil-bencil)-(pir idin-3-sulfonil)-amino)-metil)-fenoxi)-acetico o un hidrato de los mismos y procedimientos para fabricar los mismos.
WO2011154586A3 (es) Procedimientos mejorados para la preparación de derivados de quinoxalina
IN2014DN07762A (pl)